392 related articles for article (PubMed ID: 28821231)
1. Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Dastsooz H; Nemati H; Fard MAF; Fardaei M; Faghihi MA
BMC Med Genet; 2017 Aug; 18(1):87. PubMed ID: 28821231
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation.
Tschentscher A; Dekomien G; Ross S; Cremer K; Kukuk GM; Epplen JT; Hoffjan S
J Neurol Sci; 2015 Feb; 349(1-2):105-9. PubMed ID: 25592411
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration with brain iron accumulation.
Hayflick SJ; Kurian MA; Hogarth P
Handb Clin Neurol; 2018; 147():293-305. PubMed ID: 29325618
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation.
Wang ZB; Liu JY; Xu XJ; Mao XY; Zhang W; Zhou HH; Liu ZQ
Biomed Pharmacother; 2019 Oct; 118():109068. PubMed ID: 31404774
[TBL] [Abstract][Full Text] [Related]
5. On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation.
Tello C; Darling A; Lupo V; Pérez-Dueñas B; Espinós C
Clin Genet; 2018 Apr; 93(4):731-740. PubMed ID: 28542792
[TBL] [Abstract][Full Text] [Related]
6. Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.
Kurian MA; Hayflick SJ
Int Rev Neurobiol; 2013; 110():49-71. PubMed ID: 24209433
[TBL] [Abstract][Full Text] [Related]
7. NBIA Syndromes: A Step Forward from the Previous Knowledge.
Svetel M; Dragašević N; Petrović I; Novaković I; Tomić A; Kresojević N; Stanković I; Kostić V
Neurol India; 2021; 69(5):1380-1388. PubMed ID: 34747818
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria: A crossroads for lipid metabolism defect in neurodegeneration with brain iron accumulation diseases.
Aoun M; Tiranti V
Int J Biochem Cell Biol; 2015 Jun; 63():25-31. PubMed ID: 25668476
[TBL] [Abstract][Full Text] [Related]
9. Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms.
Aggarwal A; Schneider SA; Houlden H; Silverdale M; Paudel R; Paisan-Ruiz C; Desai S; Munshi M; Sanghvi D; Hardy J; Bhatia KP; Bhatt M
Mov Disord; 2010 Jul; 25(10):1424-31. PubMed ID: 20629144
[TBL] [Abstract][Full Text] [Related]
10. Clinical, neuroimaging and genetic findings in Brazilian patients with neurodegeneration with brain iron accumulation.
Araújo Salomão RP; Rezende Filho FM; Borges V; Kurian MA; Ferraz HB; Breedveld GJ; Bonifati V; Barsottini OG; Pedroso JL
Parkinsonism Relat Disord; 2024 Jun; 123():106103. PubMed ID: 38582019
[TBL] [Abstract][Full Text] [Related]
11. Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases.
Kolarova H; Tan J; Strom TM; Meitinger T; Wagner M; Klopstock T
EBioMedicine; 2022 Mar; 77():103869. PubMed ID: 35180557
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.
Hartig MB; Hörtnagel K; Garavaglia B; Zorzi G; Kmiec T; Klopstock T; Rostasy K; Svetel M; Kostic VS; Schuelke M; Botz E; Weindl A; Novakovic I; Nardocci N; Prokisch H; Meitinger T
Ann Neurol; 2006 Feb; 59(2):248-56. PubMed ID: 16437574
[TBL] [Abstract][Full Text] [Related]
13. PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation.
Dezfouli MA; Alavi A; Rohani M; Rezvani M; Nekuie T; Klotzle B; Tonekaboni SH; Shahidi GA; Elahi E
Mov Disord; 2013 Feb; 28(2):228-32. PubMed ID: 23166001
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA).
Hinarejos I; Machuca-Arellano C; Sancho P; Espinós C
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33092153
[TBL] [Abstract][Full Text] [Related]
15. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Thomas M; Hayflick SJ; Jankovic J
Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
[TBL] [Abstract][Full Text] [Related]
16. Genetics of neurodegeneration with brain iron accumulation.
Gregory A; Hayflick SJ
Curr Neurol Neurosci Rep; 2011 Jun; 11(3):254-61. PubMed ID: 21286947
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological variability in neurodegeneration with brain iron accumulation.
Vincze A; Kapás I; Molnar MJ; Kovács GG
Ideggyogy Sz; 2010 Mar; 63(3-4):129-35. PubMed ID: 20405671
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic features of PLA2G6-related paediatric neurodegeneration with brain iron accumulation.
Khan AO; AlDrees A; Elmalik SA; Hassan HH; Michel M; Stevanin G; Azzedine H; Salih MA
Br J Ophthalmol; 2014 Jul; 98(7):889-93. PubMed ID: 24522175
[TBL] [Abstract][Full Text] [Related]
19. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism.
Engel LA; Jing Z; O'Brien DE; Sun M; Kotzbauer PT
PLoS One; 2010 Sep; 5(9):e12897. PubMed ID: 20886109
[TBL] [Abstract][Full Text] [Related]
20. R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family.
Sina F; Shojaee S; Elahi E; Paisán-Ruiz C
Eur J Neurol; 2009 Jan; 16(1):101-4. PubMed ID: 19087156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
